A stark warning that ‘innovation is being hindered by regulators’ has been given by the president of EPCOT International, Girish Malhotra, in the first part of CPhI Worldwide’s sixth annual report.
Warning
“The problem we have presently is that for manufacturing technology innovations to be successful pharma companies (brand and generics) need to have an economic and commercial incentive,” added Malhotra. “It is this incentive that drives forward innovation and advancement. But the regulators — in particular the FDA — are still dictating approaches to industry without asking what the commercial justifications are to support them.”